TY - JOUR AU - Barbazán García, Jorge AU - Muinelo Romay , Laura AU - Vieito Villar, María AU - Candamio Folgar, Sonia AU - Díaz-López, A. AU - Cano, A. AU - Gómez-Tato, A. AU - Casares de Cal, M.e L AU - Abal, M. AU - López López, Rafael PY - 2014 SN - 0020-7136 UR - http://hdl.handle.net/20.500.11940/4499 AB - Circulating tumor cells (CTCs), proposed as major players in cancer dissemination, have demonstrated clinical prognostic significance in several cancer types. However, their predictive value remains unclear. Here we evaluated the clinical utility of... LA - eng KW - Adult KW - Aged KW - Aged, 80 and over KW - Antibodies, Monoclonal, Humanized KW - Antineoplastic Combined Chemotherapy Protocols KW - Bevacizumab KW - Biomarkers, Tumors KW - Camptothecin KW - Capecitabine KW - Cetuximab KW - Colorectal Neoplasms KW - Deoxycytidine KW - Epithelial-Mesenchymal Transition KW - Female KW - Fluorouracil KW - Follow-Up Studies KW - Humans KW - Irinotecan KW - Liver Neoplasms KW - Male KW - Middle Aged KW - Neoplasm Staging KW - Neoplastic Cells, Circulating KW - Organoplatinum Compounds KW - Oxaliplatin KW - Prognosis KW - Survival Rate TI - A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer DO - 10.1002/ijc.28910 T2 - INTERNATIONAL JOURNAL OF CANCER M2 - 2633 VL - 135 ER -